Thrombolysis Study Results and Bleeding Risks

The chapter discusses the results of a study on thrombolysis in patients with RV dysfunction or pulmonary hypertension, highlighting the lack of significant mortality difference between the groups and the low risk of bleeding with TPA. It emphasizes the importance of considering patient characteristics in research. The chapter also briefly mentions the MOPIT trial and raises concerns about the applicability of a landmark study on half-dose TPA for pulmonary embolism.